Betadine Rinses for Chronic Rhinosinusitis Prospective Cohort Study

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

July 28, 2017

Primary Completion Date

April 1, 2019

Study Completion Date

August 31, 2019

Conditions
Chronic Rhinosinusitis (Diagnosis)
Interventions
DRUG

Povidone-Iodine

Povidone Iodine solution 5% (0.5% available iodine) by 3MTM has been specially formulated as a nasal antiseptic. They have shown topical application to be clinically safe, tolerable and to be rapidly bacteriocidal against aerobic gram positive and gram- negative bacteria including methicillin resistant Staphylococcus aureus, methicillin resistant Staphylococcus epidermidis, vancomycin resistant Enterococcus faecium and Enterococcus faecalis (VRE) and yeast (3M study 05-011100,05-011017, 05-011322).

DRUG

Budesonide

Budesonide is is provided in nebules (1mg/2cc). Patients will place two nebules of budesonide into the 250mls of saline.

Trial Locations (1)

V6Z1Y6

St. Paul's Hospital, Vancouver

All Listed Sponsors
lead

St. Paul's Hospital, Canada

OTHER

NCT04097613 - Betadine Rinses for Chronic Rhinosinusitis Prospective Cohort Study | Biotech Hunter | Biotech Hunter